These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9157603)

  • 1. Antithrombin III-independent effect of depolymerized holothurian glycosaminoglycan (DHG) on acute thromboembolism in mice.
    Nagase H; Kitazato KT; Sasaki E; Hattori M; Kitazato K; Saito H
    Thromb Haemost; 1997 Feb; 77(2):399-402. PubMed ID: 9157603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic and anticoagulant activity of depolymerized fragment of the glycosaminoglycan extracted from Stichopus japonicus Selenka.
    Suzuki N; Kitazato K; Takamatsu J; Saito H
    Thromb Haemost; 1991 Apr; 65(4):369-73. PubMed ID: 1647552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin.
    Nagase H; Enjyoji K; Minamiguchi K; Kitazato KT; Kitazato K; Saito H; Kato H
    Blood; 1995 Mar; 85(6):1527-34. PubMed ID: 7888673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation.
    Kitazato K; Kitazato KT; Sasaki E; Minamiguchi K; Nagase H
    Thromb Res; 2003; 112(1-2):83-91. PubMed ID: 15013278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of depolymerized holothurian glycosaminoglycan (DHG) on tissue factor pathway inhibitor: in vitro and in vivo studies.
    Nagase H; Enjyoji K; Kamikubo Y; Kitazato KT; Kitazato K; Saito H; Kato H
    Thromb Haemost; 1997 Aug; 78(2):864-70. PubMed ID: 9268186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic and clinical study on the antithrombotic mechanism of glycosaminoglycan extracted from sea cucumber.
    Li Z; Wang H; Li J; Zhang G; Gao C
    Chin Med J (Engl); 2000 Aug; 113(8):706-11. PubMed ID: 11776053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of depolymerized holothurian glycosaminoglycan (DHG) on the activation of factor VIII and factor V by thrombin.
    Nagase H; Enjyoji K; Shima M; Kitazato K; Yoshioka A; Saito H; Kato H
    J Biochem; 1996 Jan; 119(1):63-9. PubMed ID: 8907177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DHG, a new depolymerized holothurian glycosaminoglycan, exerts an antithrombotic effect with less bleeding than unfractionated or low molecular weight heparin, in rats.
    Kitazato K; Kitazato KT; Nagase H; Minamiguchi K
    Thromb Res; 1996 Oct; 84(2):111-20. PubMed ID: 8897700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition.
    Momi S; Nasimi M; Colucci M; Nenci GG; Gresele P
    Haematologica; 2001 Mar; 86(3):297-302. PubMed ID: 11255277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anticoagulant and hemorrhagic effects of DHG, a new depolymerized holothurian glycosaminoglycan, on experimental hemodialysis in dogs.
    Minamiguchi K; Kitazato KT; Sasaki E; Nagase H; Kitazato K
    Thromb Haemost; 1997 Jun; 77(6):1148-53. PubMed ID: 9241748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depolymerized holothurian glycosaminoglycan (DHG), a novel alternative anticoagulant for hemodialysis, is safe and effective in a dog renal failure model.
    Minamiguchi K; Kitazato KT; Nagase H; Sasaki E; Ohwada K; Kitazato K
    Kidney Int; 2003 Apr; 63(4):1548-55. PubMed ID: 12631372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The additive effect of low molecular weight heparins on thrombin inhibition by dermatan sulfate.
    Cosmi B; Agnelli G; Young E; Hirsh J; Weitz J
    Thromb Haemost; 1993 Sep; 70(3):443-7. PubMed ID: 8259546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and anticoagulant activity of fucosylated glycosaminoglycan degraded by deaminative cleavage.
    Zhao L; Lai S; Huang R; Wu M; Gao N; Xu L; Qin H; Peng W; Zhao J
    Carbohydr Polym; 2013 Nov; 98(2):1514-23. PubMed ID: 24053834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depolymerized holothurian glycosaminoglycan and heparin inhibit the intrinsic tenase complex by a common antithrombin-independent mechanism.
    Sheehan JP; Walke EN
    Blood; 2006 May; 107(10):3876-82. PubMed ID: 16672689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Native Fucosylated Glycosaminoglycan, Its Depolymerized Derivatives on Intrinsic Factor Xase, Coagulation, Thrombosis, and Hemorrhagic Risk.
    Zhou L; Gao N; Sun H; Xiao C; Yang L; Lin L; Yin R; Li Z; Zhang H; Ji X; Zhao J
    Thromb Haemost; 2020 Apr; 120(4):607-619. PubMed ID: 32289860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exosite.
    Buyue Y; Sheehan JP
    Blood; 2009 Oct; 114(14):3092-100. PubMed ID: 19414859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The components and activities analysis of a novel anticoagulant candidate dHG-5.
    Sun H; Gao N; Ren L; Liu S; Lin L; Zheng W; Zhou L; Yin R; Zhao J
    Eur J Med Chem; 2020 Dec; 207():112796. PubMed ID: 32942073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further studies on the mechanism for the antithrombotic effects of naroparcil, an orally active thiozyloside compound.
    Masson P; Theveniaux J; Coup D; Grégoire T; Vaillot M; Dupouy D; Sié P; Boneu B; Millet J
    Thromb Haemost; 1999 Jun; 81(6):945-50. PubMed ID: 10404773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.